<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35851732</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of paediatrics and child health</Title><ISOAbbreviation>J Paediatr Child Health</ISOAbbreviation></Journal><ArticleTitle>'Long COVID': Symptom persistence in children hospitalised for COVID-19.</ArticleTitle><Pagination><StartPage>1836</StartPage><EndPage>1840</EndPage><MedlinePgn>1836-1840</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jpc.16120</ELocationID><Abstract><AbstractText Label="AIM">We aimed to describe the long-term outcome with respect to symptom persistence amongst children hospitalised for COVID-19.</AbstractText><AbstractText Label="METHODS">This was a follow-up study of 58 children and adolescents hospitalised with COVID-19. For all patients, the data were collected in a phone call to the family&#xa0;in December 2021 (9&#x2009;months after the initial study and more than 13&#x2009;months after their admission to hospital). We inquired about their current health status and obtained information, if the responding parent consented orally to participate and answer the questions.</AbstractText><AbstractText Label="RESULTS">Fifty-one children and adolescents were studied. Only five patients (10%) had persistent symptoms compatible with long-COVID; the reported symptoms include fatigue in four (8%), weakness in three (6%), exercise intolerance in two (4%) and shortness of breath in two (4%) patients. Four patients (7.8%), who did not have any symptoms of long-COVID in phase 1 of the study, reported new-onset symptoms or complaints that are potentially compatible with the diagnosis of long-COVID (weakness, myalgia, excess sputum, cough, fatigue) in the current phase.</AbstractText><AbstractText Label="CONCLUSIONS">Symptom persistence of long-COVID is infrequent amongst children hospitalised for COVID-19. Most of the symptoms of long-COVID will resolve with the passage of time and the residual symptoms are often mild and tolerable. The scientific community should carefully and clearly define long-COVID and its natural course in order to facilitate and harmonise future studies.</AbstractText><CopyrightInformation>&#xa9; 2022 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asadi-Pooya</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-2598-7601</Identifier><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemati</LastName><ForeName>Meshkat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemati</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Paediatr Child Health</MedlineTA><NlmUniqueID>9005421</NlmUniqueID><ISSNLinking>1034-4810</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chronic</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">paediatrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35851732</ArticleId><ArticleId IdType="pmc">PMC9349535</ArticleId><ArticleId IdType="doi">10.1111/jpc.16120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre CH, Murray B, Varsavsky T et al. Attributes and predictors of long COVID. Nat. Med. 2021; 27: 626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post&#x2010;COVID&#x2010;19 symptom burden: What is long&#x2010;COVID and how should we manage it? Lung 2021; 199: 113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H et al. Patients with uncomplicated COVID&#x2010;19 have long&#x2010;term persistent symptoms and functional impairment similar to patients with severe COVID&#x2010;19: A cautionary tale during a global pandemic. Clin. Infect. Dis. 2021; 73: e826&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Akbari A, Emami A et al. Risk factors associated with long COVID syndrome: A retrospective study. Iran J. Med. Sci. 2021; 46: 428&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P et al. 18F&#x2010;FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging 2021; 48: 2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Nemati H, Shahisavandi M et al. Long COVID in children and adolescents. World J. Pediatr. 2021; 17: 495&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade DT. Rehabilitation after COVID&#x2010;19: An evidence&#x2010;based approach. Clin. Med. 2020; 20: 359&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385804</ArticleId><ArticleId IdType="pubmed">32518105</ArticleId></ArticleIdList></Reference><Reference><Citation>Danet Danet A. Psychological impact of COVID&#x2010;19 pandemic in Western frontline healthcare professionals. A systematic review. Med. Clin. 2021; 156: 449&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972644</ArticleId><ArticleId IdType="pubmed">33758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB et al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat. Immunol. 2022; 23: 210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossley CJ, Kavaliunaite E, Harman K, Cook J, Ruiz G, Gupta A. Post&#x2010;acute COVID&#x2010;19 outcomes in children requiring hospitalisation. Sci. Rep. 2022; 12: 8208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113067</ArticleId><ArticleId IdType="pubmed">35581348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: An updated review. Pediatr. Infect. Dis. J. 2022; 41: 424&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8997013</ArticleId><ArticleId IdType="pubmed">35213866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG et al. Long&#x2010;term perturbation of the peripheral immune system months after SARS&#x2010;CoV&#x2010;2 infection. BMC Med. 2022; 20: 26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J et al. Long COVID 19 syndrome: Is it related to microcirculation and endothelial dysfunction? Insights from TUN&#x2010;EndCOV study. Front. Cardiovasc. Med. 2021; 8: 745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Serviente C, Decker ST, Layec G. From heart to muscle: Pathophysiological mechanisms underlying long&#x2010;term physical sequelae from SARS&#x2010;CoV&#x2010;2 infection. J. Appl. Physiol. (1985) 2022; 132: 581&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8873035</ArticleId><ArticleId IdType="pubmed">35019775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju Y, Liu J, Ng RMK et al. Prevalence and predictors of post&#x2010;traumatic stress disorder in patients with cured coronavirus disease 2019 (COVID&#x2010;19) one month post&#x2010;discharge. Eur. J. Psychotraumatol. 2021; 12: 1915576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8725742</ArticleId><ArticleId IdType="pubmed">34992752</ArticleId></ArticleIdList></Reference><Reference><Citation>Craparo G, La Rosa VL, Marino G et al. Risk of post&#x2010;traumatic stress symptoms in hospitalized and non&#x2010;hospitalized COVID&#x2010;19 recovered patients. A cross&#x2010;sectional study. Psychiatry Res. 2021; 308: 114353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688161</ArticleId><ArticleId IdType="pubmed">34968807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U et al. Long COVID symptoms in SARS&#x2010;CoV&#x2010;2&#x2010;positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross&#x2010;sectional study. Lancet Child Adolesc. Health 2022; 6: 240&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Raanes EFW, Stiles TC. Associations between psychological and immunological variables in chronic fatigue syndrome/myalgic encephalomyelitis: A systematic review. Front. Psych. 2021; 12: 716320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8650213</ArticleId><ArticleId IdType="pubmed">34887782</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N, Azzari C et al. Italian intersociety consensus on management of long covid in children. Ital. J. Pediatr. 2022; 48: 42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Pujol FE, Munblit D, Pata D, McFarland S, Simpson FK. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: A survey of 510 children. Future Microbiol. 2022; 17: 577&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD et al. Long COVID (post&#x2010;COVID&#x2010;19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022; 107: 674&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>